Envisagenics

Envisagenics is a biotechnology company that has developed a unique platform called SpliceCore to identify, test, and validate drug targets.

Envisagenics is an AI-driven biotechnology company that specializes in RNA splicing research and therapeutic development. They use their proprietary platform, which combines artificial intelligence and machine learning, to analyze RNA sequencing data and identify novel RNA splicing variants associated with diseases.